申请人:——
公开号:US20030216469A1
公开(公告)日:2003-11-20
Pro-drug compounds of the formula (I) or (II) and compositions containing them are provided that when administered to humans or other mammals provide an increased duration of active compound in the plasma compared to compounds of corresponding structure in which labile groups are not present. In the above formulae n, P, Q, R
1
, R
2
; and R
3
; are as defined in the specification. The compounds may be used to treat a range of neurological conditions. e.g. epilepsy or pain.
提供了公式(I)或(II)的促药物化合物以及含有它们的组合物,当向人类或其他哺乳动物施用时,与相应结构中不含不稳定基团的化合物相比,在血浆中提供活性化合物的持续时间增加。在上述公式中,n、P、Q、R1、R2和R3如规范中所定义。这些化合物可用于治疗一系列神经疾病,例如癫痫或疼痛。